A double-blind, randomized, placebo-controlled, phase II study of the efficacy and safety of Lau-7B in the treatment of cystic fibrosis in adults (APPLAUD)

Project Details

StatusFinished
Effective start/end date1/01/2031/12/20

Funding

  • Avance Clinical: A$27,725.00
  • Avance Clinical: A$45,000.00
  • Avance Clinical: A$42,228.00
  • Avance Clinical: A$10,459.00